DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

Cambrex Corp (NYSE: CBM)

23.53 0.30 (1.29%)

REAL-TIME: Last trade at

Extended Hours: $23.53 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

CBM $23.53 1.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.62
Previous Close $23.23
Daily Range $23.40 - $23.62
52-Week Range $15.20 - $24.45
Market Cap $729.3M
P/E Ratio 18.44
Dividend (Yield) $0.00 (0.0%)
Volume 136,298
Average Daily Volume 201,896
Current FY EPS $1.13

Sector

Healthcare

Industry

Drugs

Cambrex Corp (CBM) Description

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics. Website: http://www.cambrex.com/

News & Commentary

Why Cambrex Corporation Shares Dipped

Cambrex shares dive following the company's first-quarter earnings results. Find out whether this dip is a buying opportunity or a reason to avoid this stock.

Can the Rally in Cambrex (CBM) Shares Continue? - Tale of the Tape

Cambrex's (CBM) CEO Steve Klosk on Q3 2014 Results -- Earnings Call Transcript

Cambrex (CBM) Q3 2014 Results - Earnings Call Webcast

Commit To Buy Cambrex Corp At $15, Earn 11.3% Annualized Using Options

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape

Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape

Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape

Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape

CorMedix Files IND Application for Neutrolin in the US - Analyst Blog

Ambit Biosciences (AMBI) Soars: Stock Adds 87.1% - Tale of the Tape

See More CBM News...

CBM's Top Competitors

CBM $23.53 (1.29%)
Current stock: CBM
TMO $127.52 (2.20%)
Current stock: TMO
ILMN $187.29 (3.36%)
Current stock: ILMN
WAT $114.26 (0.80%)
Current stock: WAT